Inhibition of Sp1-dependent transcription and antitumor activity of the new aureolic acid analogues mithramycin SDK and SK in human ovarian cancer xenografts
- 1 August 2010
- journal article
- Published by Elsevier BV in Gynecologic Oncology
- Vol. 118 (2), 182-188
- https://doi.org/10.1016/j.ygyno.2010.03.020
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- The biology of ovarian cancer: new opportunities for translationNature Reviews Cancer, 2009
- Tolfenamic acid inhibits esophageal cancer through repression of specificity proteins and c-MetCarcinogenesis: Integrative Cancer Research, 2009
- Curcumin Decreases Specificity Protein Expression in Bladder Cancer CellsCancer Research, 2008
- Early Events in the Pathogenesis of Epithelial Ovarian CancerJournal of Clinical Oncology, 2008
- Downregulation of XIAP expression in ovarian cancer cells induces cell death in vitro and in vivoInternational Journal of Cancer, 2007
- Entropically-driven binding of mithramycin in the minor groove of C/G-rich DNA sequencesNucleic Acids Research, 2007
- Regulation of vascular endothelial growth factor receptor-2 expression in pancreatic cancer cells by Sp proteinsBiochemical and Biophysical Research Communications, 2006
- Novel GC-rich DNA-binding compound produced by a genetically engineered mutant of the mithramycin producer Streptomyces argillaceus exhibits improved transcriptional repressor activity: implications for cancer therapyNucleic Acids Research, 2006
- Sp transcription factor family and its role in cancerEuropean Journal Of Cancer, 2005
- Inhibition of c-src Transcription by Mithramycin: Structure−Activity Relationships of Biosynthetically Produced Mithramycin Analogues Using the c-src Promoter as TargetBiochemistry, 2003